RXST financial statements and SEC filings

RXST annual income statement

Fiscal period endRevenueOperating incomeNet incomeSEC filing
2025-12-31$134.48M-$48.19M-$38.94M10-K
2024-12-31$139.93M-$36.86M-$27.45M10-K
2023-12-31$89.08M-$50.09M-$48.61M10-K
2022-12-31$49.01M-$63.32M-$66.76M10-K
2021-12-31$22.59M-$52.79M-$48.69M10-K
2020-12-31$14.68M-$35.41M$3.37M10-K

RXST annual balance sheet

Fiscal period endAssetsLiabilitiesEquitySEC filing
2025-12-31$311.81M$36.13M$275.68M10-Q
2024-12-31$318.56M$37.33M$281.24M10-K
2023-12-31$182.55M$22.19M$160.36M10-K
2022-12-31$150.16M$60.26M$89.90M10-K
2021-12-31$192.72M$54.48M$138.24M10-K
2020-12-31$100.68M$44.91M-$430.59M10-K

RXST annual cash flow

Fiscal period endOperating cash flowCapital expenditureFinancing cash flowSEC filing
2025-12-31-$15.51M-$3.83M$1.86M10-K
2024-12-31-$16.95M-$5.44M$123.32M10-K
2023-12-31-$41.59M-$4.81M$61.52M10-K
2022-12-31-$58.85M-$2.39M$6.33M10-K
2021-12-31-$44.71M-$1.94M$137.34M10-K
2020-12-31-$35.20M-$2.54M$25.24M10-K